| Year |
Citation |
Score |
| 2013 |
Hu Y, Chen Y, Ding L, He X, Takahashi Y, Gao Y, Shen W, Cheng R, Chen Q, Qi X, Boulton ME, Ma JX. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. Proceedings of the National Academy of Sciences of the United States of America. 110: 15401-6. PMID 24003152 DOI: 10.1073/Pnas.1307211110 |
0.314 |
|
| 2013 |
Chen Y, Hu Y, Lin M, Jenkins AJ, Keech AC, Mott R, Lyons TJ, Ma JX. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Diabetes. 62: 261-72. PMID 23043158 DOI: 10.2337/Db11-0413 |
0.302 |
|
| 2012 |
Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M, Le YZ, Ge J, Ma JX. Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Investigative Ophthalmology & Visual Science. 53: 6197-206. PMID 22915031 DOI: 10.1167/Iovs.11-8936 |
0.306 |
|
| 2012 |
Lee K, Hu Y, Ding L, Chen Y, Takahashi Y, Mott R, Ma JX. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy. Diabetes. 61: 2948-57. PMID 22891217 DOI: 10.2337/Db11-0300 |
0.321 |
|
| 2011 |
Takahashi Y, Moiseyev G, Chen Y, Nikolaeva O, Ma JX. An alternative isomerohydrolase in the retinal Müller cells of a cone-dominant species. The Febs Journal. 278: 2913-26. PMID 21676174 DOI: 10.1111/J.1742-4658.2011.08216.X |
0.301 |
|
| 2010 |
Zhou T, Hu Y, Chen Y, Zhou KK, Zhang B, Gao G, Ma JX. The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Investigative Ophthalmology & Visual Science. 51: 4371-9. PMID 19875668 DOI: 10.1167/Iovs.09-4278 |
0.309 |
|
| 2009 |
Bai Y, Ma JX, Guo J, Wang J, Zhu M, Chen Y, Le YZ. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. The Journal of Pathology. 219: 446-54. PMID 19768732 DOI: 10.1002/Path.2611 |
0.302 |
|
| 2009 |
Chen Y, Hu Y, Moiseyev G, Zhou KK, Chen D, Ma JX. Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency. Microvascular Research. 78: 119-27. PMID 19281829 DOI: 10.1016/J.Mvr.2009.02.005 |
0.316 |
|
| 2006 |
Takahashi Y, Chen Y, Moiseyev G, Ma JX. Two point mutations of RPE65 from patients with retinal dystrophies decrease the stability of RPE65 protein and abolish its isomerohydrolase activity. The Journal of Biological Chemistry. 281: 21820-6. PMID 16754667 DOI: 10.1074/Jbc.M603725200 |
0.303 |
|
| 2006 |
Chen Y, Moiseyev G, Takahashi Y, Ma JX. RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice. Investigative Ophthalmology & Visual Science. 47: 1177-84. PMID 16505056 DOI: 10.1167/Iovs.05-0965 |
0.301 |
|
| 2005 |
Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma JX. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proceedings of the National Academy of Sciences of the United States of America. 102: 12413-8. PMID 16116091 DOI: 10.1073/Pnas.0503460102 |
0.305 |
|
| Show low-probability matches. |